Charles RamseyCharlesRamsey

Cencora on its acquisition of Retina Consultants of America for cash, based on an enterprise value of approximately $4.6 billion.

CrowdStrike on its $740 million acquisition of SGNL and its acquisitions of Seraphic Security, Onum, Pangea and Adaptive Shield.

DSV on its €14.3 billion acquisition of Schenker AG from Deutsche Bahn.

Evonik Industries in connection with the FTC’s investigation into Evonik’s $630 million acquisition of the precipitated silica business from J.M. Huber.

Fever-Tree on its strategic partnership with Molson Coors Beverage Company in the U.S.

Hewlett Packard Enterprise on the U.S. merger control aspects of its $14 billion acquisition of Juniper Networks.

Infineon Technologies on its $830 million acquisition of GaN Systems.

Japan Tobacco on its $2.4 billion acquisition of U.S. cigarette maker Vector Group.

Johnson & Johnson on its $850 million acquisition of Proteologix, a biotechnology company focused on bispecific antibodies for immune-mediated diseases, and its $2 billion acquisition of Ambrx Biopharma, a biotech company developing next generation ADCs for prostate cancer.

Jungheinrich AG on its $375 million acquisition of Storage Solutions Group.

Kiekert AG and its North American subsidiary in the global auto parts price-fixing investigations, including a negotiated plea agreement with the DOJ and follow-on litigation in the U.S.

Lowe’s Companies on its $8.8 billion acquisition of Foundation Building Materials.

Messer Group and CVC Capital Partners with respect to their $3.3 billion acquisition of North American industrial gas assets required to be divested as a result of the FTC’s investigation of Linde/Praxair.

Novartis on the merger control aspects of its $1.75 billion acquisition of U.S. radiopharmaceutical company Mariana Oncology.

Novartis on its $2.89 billion takeover of MorphoSys AG.

Penske Automotive Group on its approximately $520 million acquisition of Longo Toyota and Longo Lexus.

Roivant Sciences on its $7.1 billion sale of Telavant, the developer of treatments for IBS.

Sanofi S.A. on its acquisition of Vigil Neuroscience.

Salesforce on its acquisition of Convergence.ai, an AI agent company recognized for developing advanced systems that perform complex, human-like tasks in digital environments.

ServiceNow on its $7.75 billion acquisition of Armis, its acquisitions of Veza, Mission Secure and Logik.ai, and its joint $1.5 billion investment, alongside Salesforce, in Genesys.

Standard BioTools on the sale of its SomaLogic business to Illumina for $425 million in cash and milestone payments.

Starbucks on global merger control and ongoing competition compliance aspects of its $7.15 billion global coffee alliance with Nestle.

Subsea7 on the U.S. merger control aspects of its proposed multibillion combination with Saipem (offshore energy construction and maintenance sector).

Terns Pharmaceuticals in its $6.7 billion acquisition by Merck.

Viterra and its shareholders on global merger control of its transformative merger with Bunge. This $34 billion transaction marks the largest grain trading merger in over a decade, establishing a cutting-edge global agribusiness leader.

Yokohama Rubber on its acquisition of Trelleborg Wheel Systems Holding AB for an enterprise value of over €2 billion and on Yokohama''s $905 million acquisition of Goodyear’s off-the-road tire business.